
Webinar
Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring

Webinar
Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring

Clare Paterson, PhD
Associate Director of Clinical Research, SomaLogic

Jessica Chadwick, PhD
Scientist, SomaLogic
In this webinar you’ll learn how the power of large-scale proteomics can be leveraged for multiple divergent applications in the field of oncology ‒ from monitoring the cardiotoxic effects of chemotherapy treatment to developing blood-based protein-only tests for stratifying lung cancer susceptibility.
Watch this webinar to discover how:
- Proteomic risk scores can be used to identify high risk patients and monitor for adverse effects
- To analyze thousands of proteins to develop cancer susceptibility models
High-throughput proteomics can inform and impact patients' standard of care
Advertisement